Gewählte Publikation:
Rabitsch, W; Knöbl, P; Prinz, E; Keil, F; Greinix, H; Kalhs, P; Worel, N; Jansen, M; Hörl, WH; Derfler, K.
Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorption.
Bone Marrow Transplant. 2003; 32(10):1015-1019
Doi: 10.1038/sj.bmt.1704264
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Greinix Hildegard
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Delayed donor red cell engraftment and prolonged red cell aplasia (PRCA) are well-recognized complications of major ABO-incompatible myeloablative and non-myeloablative hematopoietic stem cell transplantation (HSCT). There is an intense debate about the impact on outcome, severity of hemolysis, association with graft-versus-host disease and survival after blood group-incompatible stem cell transplantation. Therefore, therapeutic strategies should be considered to avoid these possible complications. We present five patients, who received allogeneic HSCT from human leukocyte antigen-identical donors for hematological malignancies, which were treated with Ig-Therasorb immunoadsorption (five treatments/week) to remove persisting incompatible isohemagglutinins. After a median of 17 treatments (range 9-25), all the patients became transfusion independent with the presentation of donor's blood group. No side effects occurred during treatment. Ig-Therasorb immunoadsorption seems to be a promising therapeutic method for rapid, efficient and safe elimination for persisting isohemagglutinins for patients with PRCA after allogeneic hematological stem cell transplantation.
- Find related publications in this database (using NLM MeSH Indexing)
-
ABO Blood-Group System - immunology
-
Adult -
-
Blood Group Incompatibility -
-
Female -
-
Hemagglutinins - isolation & purification
-
Hematologic Neoplasms - complications Hematologic Neoplasms - therapy
-
Hematopoietic Stem Cell Transplantation - adverse effects Hematopoietic Stem Cell Transplantation - methods
-
Histocompatibility -
-
Humans -
-
Immunosorbent Techniques -
-
Male -
-
Middle Aged -
-
Red-Cell Aplasia, Pure - etiology Red-Cell Aplasia, Pure - therapy
-
Transplantation, Homologous -
-
Treatment Outcome -
- Find related publications in this database (Keywords)
-
red cell aplasia
-
stem cell transplantation
-
immunoadsorption